Jay Evans

Jay Evans is the Chief Scientific and Strategy Officer at Inimmune Corporation (Missoula, MT) Prior to co-founding Inimmune Dr. Evans spent 16 years at GSK Vaccines (Hamilton, MT) working on the identification, characterization and development of novel vaccines and immunomodulators. He has published over 50 peer reviewed research articles on vaccines, adjuvants and immunotherapy.
His research is focused on the discovery and development of novel vaccines, adjuvants and immunotherapeutics across a broad range of targets including SARS-CoV-2, influenza virus, pertussis, tuberculosis, pseudomonas, cancer immunotherapy, opioid addiction and allergy.